MHRA Drug Safety Update September 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 2 September 2022) has been published and includes articles on:

  • Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations
  • Rucaparib (Rubraca▼): withdrawal of third-line treatment indication
  • COVID-19 vaccines and medicines: updates for September 2022
  • Letters and medicine recalls sent to healthcare professionals in August 2022

To see the latest MHRA Drug Safety Updates in full, visit the website.